Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

NCT04176250 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: TBA-7371
DRUG: TBA-7371
DRUG: TBA-7371
DRUG: TBA-7371
DRUG: TBA-7371
DRUG: HRZE

Sponsor

Gates Medical Research Institute